Incyte Forms Two New Academic Alliances To Study Disease | GenomeWeb

NEW YORK, Dec 13 - Incyte Genomics said Wednesday it has formed two genomic research partnerships with leading academic institutions to study common diseases.

The company is partnering with the University of California San Francisco to study prostate cancer, and with CARIM, the Maastricht Cardiovascular Research Institute in the Netherlands to study cardiovascular disease.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.